Views 417
Citations 0
Comment & Response
March 17, 2015

BK Virus Prophylaxis With Levofloxacin—Reply

Author Affiliations
  • 1Division of Nephrology, University of British Columbia, Vancouver, Canada
  • 2Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada
  • 3Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2015;313(11):1165-1166. doi:10.1001/jama.2015.1058

In Reply Our trial to test a strategy to prevent BK infection was motivated by limitations of the current reactionary approach to management that involves reduction in immunosuppression after development of infection. However, because the alternative surrogate outcome of immunosuppression reduction suggested by Dr Landman was not evaluated in our trial, we cannot offer a formal opinion regarding its potential use. In our opinion, because the decision to reduce immunosuppression may be influenced by many other factors, including risk of rejection, this outcome may be difficult to implement in a clinical trial.

First Page Preview View Large
First page PDF preview
First page PDF preview